DaVita Venture Group: Funding, Team & Investors | Startup Intros

Loading organizations...

DaVita Venture Group: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 5, 2026	Greater Good Health	$33.0M Debt / Series B	Branden Fini	Epsilon, Flare Capital Partners, Granite Financial Holdings, Health Velocity Capital, HSBC Innovation Banking, LRVHealth, Martin Ventures, Optum Ventures
Aug 14, 2023	Xeltis	$13.7M Series D Extension	EIC Fund	Grand Pharmaceutical Group, Kurma Partners, LSP, VI Partners, Ysios Capital
Feb 23, 2023	Xeltis	$34.0M Series D Extension	—	Steve Phillips, Frank Zhou, LSP
May 1, 2021	Heartbeat Health	$20.0M Series B	Echo Health Ventures	.406 Ventures, Ascension Ventures, Avalon Ventures, Designer Fund, Kindred Ventures, Lerer Hippeau, Max Ventures, Optum Ventures
Dec 1, 2020	SameSky Health	$17.0M Series B	Magnetic Ventures	7wire Ventures, Alumni Ventures, Baukunst, Modern Venture Partners, New Enterprise Associates (NEA), Victor Oladipo, American Heart Association, Javier Rodriguez, Impact Engine, Salesforce Ventures, Tufts Health Plan, Wanxiang America Corporation
May 1, 2020	Wellth	$10.0M Series A	Boehringer Ingelheim, Dr. Gerrit Seidel	Boehringer Ingelheim Venture Fund, Cyberstarts VC, Distributed Ventures, Esplanade HealthTech Ventures, Lightbank, AXA Venture Partners, I2BF Global Ventures, New York Life, NFP Ventures, Partnership Fund for New York City, Rock Health
	R1 Therapeutics	$78.0M R1 Therapeutics Series A	Abingworth, F-Prime Capital, Andrew Sinclair, Chong Xu, DaVita Venture Group, Chong Xu	Ben Auspitz, SymBiosis, U.S. Renal Care